Camber Launches Generic Lyrica®

Piscataway, NJ, March 24, 2020– Camber Pharmaceuticals is pleased to announce that it has launched Pregabalin Capsules, which is the generic version of Lyrica® capsules. Pregabalin capsules is used to treat pain caused by nerve damage due to diabetes or shingles infection.
Pregabalin is available from Camber in 25, 50, 75, 100, 150, 200, 225, 300mg- 90ct count bottles.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection